找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antiviral Drug Discovery and Development; Xinyong Liu,Peng Zhan,Vasanthanathan Poongavanam Book 2021 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
查看: 8115|回復(fù): 54
樓主
發(fā)表于 2025-3-21 19:54:52 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Antiviral Drug Discovery and Development
影響因子2023Xinyong Liu,Peng Zhan,Vasanthanathan Poongavanam
視頻videohttp://file.papertrans.cn/159/158704/158704.mp4
發(fā)行地址Summarizes antiviral drug design and discovery approaches.Provides the latest update in the field of antiviral therapeutics.Includes antiviral research of coronaviruses
學(xué)科分類Advances in Experimental Medicine and Biology
圖書(shū)封面Titlebook: Antiviral Drug Discovery and Development;  Xinyong Liu,Peng Zhan,Vasanthanathan Poongavanam Book 2021 The Editor(s) (if applicable) and The
影響因子.This book summarizes state-of-the-art antiviral drug design and discovery approaches starting from natural products to de novo design, and provides a timely update on recently approved antiviral drugs and compounds in advanced clinical development. Special attention is paid to viral infections with a high impact on the world population or highly relevant from the public health perspective (HIV, hepatitis C, influenza virus, etc.).? In these chapters, limitations associated with adverse effects and emergence of drug resistance are discussed in detail. In addition to classical antiviral strategies, chapters will be dedicated to discuss the non-classical drug development strategies to block viral infection, for instance, allosteric inhibitors, covalent antiviral agents, or antiviral compounds targeting protein–protein interactions. Finally, current prospects for producing broad-spectrum antiviral inhibitors will be also addressed...The book is distinctive in providing the most recent update in the rapidly evolving field of antiviral therapeutics. Authoritative reviews are written by international scientists well known for their contributions in their topics of research, which makes t
Pindex Book 2021
The information of publication is updating

書(shū)目名稱Antiviral Drug Discovery and Development影響因子(影響力)




書(shū)目名稱Antiviral Drug Discovery and Development影響因子(影響力)學(xué)科排名




書(shū)目名稱Antiviral Drug Discovery and Development網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Antiviral Drug Discovery and Development網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Antiviral Drug Discovery and Development被引頻次




書(shū)目名稱Antiviral Drug Discovery and Development被引頻次學(xué)科排名




書(shū)目名稱Antiviral Drug Discovery and Development年度引用




書(shū)目名稱Antiviral Drug Discovery and Development年度引用學(xué)科排名




書(shū)目名稱Antiviral Drug Discovery and Development讀者反饋




書(shū)目名稱Antiviral Drug Discovery and Development讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:47:02 | 只看該作者
An Update on Antiretroviral Therapy, efforts during the last 40?years have led to the approval of over 30 antiretroviral drugs and the introduction of combination therapies that have turned HIV infection into a chronic but manageable disease. In this chapter, we provide an update on current available drugs and treatments, as well as f
板凳
發(fā)表于 2025-3-22 01:14:44 | 只看該作者
地板
發(fā)表于 2025-3-22 07:48:42 | 只看該作者
5#
發(fā)表于 2025-3-22 12:14:44 | 只看該作者
Moving Fast Toward Hepatitis B Virus Elimination,(pegylated or non-pegylated). These treatments can control viral replication and improve survival; however, they do not eliminate the virus and therefore require long-term continued therapy. In addition, there are significant concerns about virus rebound on discontinuation of therapy and the develop
6#
發(fā)表于 2025-3-22 16:23:27 | 只看該作者
Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection,stage of HCV infection, 18–34% of individuals exhibit spontaneous clearance. However, the remaining 66–82% of infected individuals progress to chronic HCV infection and are at subsequent risk of progression to hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic hepatitis C progr
7#
發(fā)表于 2025-3-22 18:15:12 | 只看該作者
8#
發(fā)表于 2025-3-22 23:38:16 | 只看該作者
Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Mea prevention and treatment of influenza virus infection and disease. Today, the number of antiviral molecules approved for the treatment of influenza is relatively limited, and their use is threatened by the emergence of viral strains with resistance mutations. There is therefore a real need to expan
9#
發(fā)表于 2025-3-23 04:20:42 | 只看該作者
10#
發(fā)表于 2025-3-23 07:11:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 09:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
家居| 新野县| 日土县| 南京市| 南通市| 乐安县| 三原县| 海口市| 明光市| 平安县| 大姚县| 高淳县| 获嘉县| 城市| 喀什市| 云浮市| 蓝田县| 万荣县| 乾安县| 扬中市| 从化市| 会东县| 襄垣县| 汉阴县| 乡城县| 柳州市| 启东市| 长岭县| 同德县| 和平县| 邹城市| 龙山县| 濮阳市| 怀柔区| 澄城县| 诸暨市| 射洪县| 永修县| 右玉县| 胶南市| 丹凤县|